Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist.
J Immunother Cancer. 2021 Jan;9(1):e001762. doi: 10.1136/jitc-2020-001762.
J Immunother Cancer. 2021.
PMID: 33500260
Free PMC article.